Polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-di hydro3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]m ethyl]-benzonitrile and methods of use therefor

Details for Australian Patent Application No. 2006292637 (hide)

Owner Takeda Pharmaceutical Company Limited

Inventors Andres, Mark; Lorimer, Keith

Agent Griffith Hack

Pub. Number AU-A-2006292637

PCT Pub. Number WO2007/035372

Priority 60/718,133 16.09.05 US

Filing date 13 September 2006

Wipo publication date 29 March 2007

International Classifications

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/035372 Priority application(s): WO2007/035372

5 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006292641-Meter electronics and methods for generating a drive signal for a vibratory flowmeter

2006292620-Modulators of metabolism and the treatment of disorders related thereto